Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation

BMC Cardiovascular Disorders

António M Leitão-Marques¹  Ana Botelho¹  Joana Trigo¹  Joana Pimenta¹  Sérgio Barra¹  Andreia Fernandes¹  Luís Paiva¹  Ana Faustino¹  Rui Providência² 

[1] Centro Hospitalar e Universitário de Coimbra, Serviço de Cardiologia, Coimbra, Portugal;Faculty of Medicine, University of Coimbra, Coimbra, Portugal

关键词: Mean platelet volume;    Left atrial appendage thrombus;    Stroke;    Atrial fibrillation;   

Others  :  857663
DOI  :  10.1186/1471-2261-13-40

 received in 2013-02-04, accepted in 2013-06-06,  发布年份 2013

【 摘 要 】

Background

Mean platelet volume has been associated with stroke in patients with atrial fibrillation. However, its role as a predictor of left atrial stasis, assessed by transesophageal echocardiography, in patients with non-valvular atrial fibrillation has not yet been clarified.

Methods

Single center cross-sectional study comprising 427 patients admitted to the emergency department due to symptomatic atrial fibrillation and undergoing transesophageal echocardiogram evaluation for exclusion of left atrial appendage thrombus before cardioversion. All patients had a complete blood count performed in the 12 hours prior to transesophageal echocardiogram. Markers of left atrial stasis were sought: left atrial appendage thrombus, dense spontaneous echocardiographic contrast and low flow velocities in the left atrial appendage. The presence of at least one of the former markers of left atrial stasis was designated left atrial abnormality. Binary logistic multivariate analysis was used for obtaining models for the prediction of transesophageal echocardiogram endpoints.

Results

Left atrial appendage thrombus was found in 12.2%, dense spontaneous echocardiographic contrast in 29.7%, low flow velocities in 15.3% and left atrial abnormality in 34.2%. Mean platelet volume (exp β = 3.41 p = 0.048) alongside with previous stroke or transient ischemic attack (exp β = 5.35 p = 0.005) and troponin I (exp β = 5.07 p = 0.041) were independent predictors of left atrial appendage thrombus. Mean platelet volume was also incorporated in the predictive models of dense spontaneous echocardiographic contrast, low flow velocities and left atrial abnormality, adding predictive value to clinical, echocardiographic and laboratory variables.

Conclusions

These findings suggest that mean platelet volume may be associated with the presence of markers of left atrial stasis, reinforcing a likely cardioembolic mechanism for its association with stroke in patients with non-valvular atrial fibrillation.

【 授权许可】

   
2013 Providência et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D’Agostino RB: Stroke severity in atrial fibrillation: the framingham study. Stroke 1996, 27(10):1760-1764.
• [2]Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines-CPG; Document Reviewers: 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation--developed with the special contribution of the European heart rhythm association. Europace 2012, 14(10):1385-1413.
• [3]Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, et al.: 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012, 14(4):528-606.
• [4]Ha SI, Choi DH, Ki YJ, Yang JS, Park G, Chung JW, Koh YY, Chang KS, Hong SP: Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets 2011, 22(6):408-414.
• [5]Turfan M, Erdogan E, Ertas G, Duran M, Murat SN, Celik E, Baydar C, Tasal A, Vatankulu MA, Sevgili E, Kul S, Yoldas T, Goktekin O: Usefulness of mean platelet volume for predicting stroke risk in atrial fibrillation patients. Blood Coagul Fibrinolysis 2013, 24(1):55-58.
• [6]Blackshear J, Odell J: Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996, 61:755-759.
• [7]Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG: Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation: stroke prevention in atrial fibrillation III investigators. J Am Coll Cardiol 1998, 31(7):1622-1626.
• [8]Fatkin D, Kelly RP, Feneley MP: Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994, 23:961-969.
• [9]Providência R, Faustino A, Paiva L, Trigo J, Botelho A, Nascimento J, Leitão-Marques AM: Cardioversion safety in patients with nonvalvular atrial fibrillation: which patients can be spared transesophageal echocardiography? Blood Coagul Fibrinolysis 2012, 23(7):597-602.
• [10]Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010, 137(2):263-272.
• [11]Providência R, Paiva L, Faustino A, Botelho A, Trigo J, Casalta-Lopes J, Nascimento J, Leitão-Marques AM: Cardiac troponin I: prothrombotic risk marker in non-valvular atrial fibrillation. Int J Cardiol 2012. Epub ahead of print
• [12]Tang RB, Liu XH, Kalifa J, Li ZA, Dong JZ, Yang Y, Liu XP, Long DY, Yu RH, Ma CS: Body mass index and risk of left atrial thrombus in patients with atrial fibrillation. Am J Cardiol 2009, 104(12):1699-1703.
• [13]Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L: Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy. Circulation 2012, 125(13):1605-1616.
• [14]Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR: Size dependent platelet subpopulations: relationship of platelet volume to ultra-structure, enzymatic activity and function. Br J Haematol 1982, 50:509-519.
• [15]Machin SJ, Briggs C: Mean platelet volume: a quick, easy determinant of thrombotic risk? J Thromb Haemost 2009, 8:146-147.
• [16]Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD: Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011, 17:47-58.
• [17]Chu SG, Becker MD, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS: Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2009, 8:148-156.
• [18]Colkesen Y, Acil T, Abayli B, Yigit F, Katircibasi T, Kocum T, Demircan S, Sezgin A, Ozin B, Muderrisoglu H: Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation? Blood Coagul Fibrinolysis 2008, 19(5):411-414.
• [19]Yuce M, Cakici M, Davutoglu V, Ozer O, Sari I, Ercan S, Sucu M, Dogan A, Yavuz F: Relationship between mean platelet volume and atrial thrombus in patients with atrial fibrillation. Blood Coagul Fibrinolysis 2010, 21(8):722-725.
• [20]Zotz RJ, Müller M, Genth-Zotz S, Darius H: Spontaneous echo contrast caused by platelet and leukocyte aggregates? Stroke 2001, 32(5):1127-1133.
• [21]Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA 2001, 285(22):2864-2870.
• [22]Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Selmer C, Ahlehoff O, Olsen AM, Gislason GH, Torp-Pedersen C: Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011, 342:d124.
• [23]Providência R, Botelho A, Trigo J, Quintal N, Nascimento J, Mota P, Leitão-Marques A: Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters. Europace 2012, 14(1):36-45.
• [24]Ayirala S, Kumar S, O’Sullivan DM, Silverman DI: Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr 2011, 24(5):499-505.
• [25]Kleemann T, Becker T, Strauss M, Schneider S, Seidl K: Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr 2009, 10:383-388.